產(chǎn)品詳情
簡單介紹：
Anti-Phospho-SATB1 (Ser47)抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-Phospho-SATB1 (Ser47)抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Phospho-SATB1 (Ser47)
Cat. Number:
Anti-Phospho-SATB1 (Ser47)抗體KL-3390R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
SATB1 selectively binds double-stranded, special AT-rich RNA sequences in which 1 strand exclusively consists of well-mixed A, T, and C nucleotides (ATC sequences). It complexes mainly with p300 and this complex Anti-Phospho-SATB1 (Ser47)抗體can bind to the gp91phox promoter and repress transcriptional activity. Its ability to repress transcription is regulated by nuclear matrix binding. It is expressed predominantly in the thymus.
Also known as:
DNA binding protein SATB1; DNA-binding protein SATB1; SATB homeobox 1; SATB1; SATB1_HUMAN; Special AT rich sequence binding protein 1 (binds to nuclear matrix/scaffold associating DNA); Special ATAnti-Phospho-SATB1 (Ser47)抗體 rich sequence binding protein 1; Special AT-rich sequence-binding protein 1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Chicken, Dog, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated Anti-Phospho-SATB1 (Ser47)抗體Synthesised phosphopeptide derived from human SATB1 around the phosphorylation site of Ser47.
●
Predicted Molecular Weight: 86kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-Phospho-SATB1 (Ser47)抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-Phospho-SATB1 (Ser47)抗體
Optimal working dilutions must be determined by the end user.
